Literature DB >> 30230945

MicroRNA-886-3P functions as a tumor suppressor in small cell lung cancer.

Jie Shen1, Wei Zhou2, Nan Bi3, Yong-Mei Song2, Fu-Quan Zhang1, Qi-Min Zhan2, Lv-Hua Wang3.   

Abstract

Small cell lung cancer (SCLC) is a highly aggressive disease and miRNAs may play an important role in modulating SCLC progression. We have previously screened 924 miRNAs and found that miR-886-3P was negatively associated with SCLC survival. In the current study, we further investigated the role of miR-886-3P mimic in regulating SCLC cell phenotypic alteration in vitro and xenograft tumor formation in vivo. We found that transfection of miR-886-3P mimic significantly inhibited SCLC cell proliferation, migration, and colony formation, and induced mesenchymal-epithelial transition (MET) by suppressing TGF-ß1 synthesis in vitro. Furthermore, intra-tumor injection of miR-886-3P mimic lead to necrosis and suppression of tumor invasion to the surrounding tissue in the subcutaneous xenograft tumor, and intra-vein injection of miR-886-3P mimic suppressed xenograft lung cancer growth in vivo. These findings suggested that miR-886-3P functions as a tumor suppressor in SCLC and thus, it might be a potential therapeutic molecule in the treatment of lung cancer.

Entities:  

Keywords:  Small cell lung cancer; TGF-ß1; aggressive disease; cancer biology; fetal bovine serum; miR-886-3P; miRNAs; pGL3-luciferase

Mesh:

Substances:

Year:  2018        PMID: 30230945      PMCID: PMC6301808          DOI: 10.1080/15384047.2018.1491505

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  30 in total

Review 1.  Second-line chemotherapy for small-cell lung cancer (SCLC).

Authors:  Young Hak Kim; Michiaki Mishima
Journal:  Cancer Treat Rev       Date:  2010-06-26       Impact factor: 12.111

Review 2.  Immune-based Therapies for Non-small Cell Lung Cancer.

Authors:  Hind Rafei; Ehab El-Bahesh; Antoine Finianos; Samah Nassereddine; Imad Tabbara
Journal:  Anticancer Res       Date:  2017-02       Impact factor: 2.480

3.  Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.

Authors:  Shusuke Toden; Yoshinaga Okugawa; Thomas Jascur; Dominik Wodarz; Natalia L Komarova; Constanze Buhrmann; Mehdi Shakibaei; C Richard Boland; Ajay Goel
Journal:  Carcinogenesis       Date:  2015-02-04       Impact factor: 4.944

4.  Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer--what limits limited disease?

Authors:  Patrick Micke; Andreas Faldum; Tsegay Metz; Kai-Michael Beeh; Fernando Bittinger; Jan-Georg Hengstler; Roland Buhl
Journal:  Lung Cancer       Date:  2002-09       Impact factor: 5.705

5.  MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma.

Authors:  Wei-Chih Tsai; Paul Wei-Che Hsu; Tsung-Ching Lai; Gar-Yang Chau; Ching-Wen Lin; Chun-Ming Chen; Chien-Der Lin; Yu-Lun Liao; Jui-Ling Wang; Yat-Pang Chau; Ming-Ta Hsu; Michael Hsiao; Hsien-Da Huang; Ann-Ping Tsou
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

Review 6.  MicroRNA and cancer.

Authors:  Martin D Jansson; Anders H Lund
Journal:  Mol Oncol       Date:  2012-10-09       Impact factor: 6.603

7.  TGF-β1-ROS-ATM-CREB signaling axis in macrophage mediated migration of human breast cancer MCF7 cells.

Authors:  Rajshri Singh; Bhavani S Shankar; Krishna B Sainis
Journal:  Cell Signal       Date:  2014-04-03       Impact factor: 4.315

8.  Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT.

Authors:  Constanze Buhrmann; Patricia Kraehe; Cora Lueders; Parviz Shayan; Ajay Goel; Mehdi Shakibaei
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

9.  mir-660-p53-mir-486 Network: A New Key Regulatory Pathway in Lung Tumorigenesis.

Authors:  Cristina Borzi; Linda Calzolari; Giovanni Centonze; Massimo Milione; Gabriella Sozzi; Orazio Fortunato
Journal:  Int J Mol Sci       Date:  2017-01-23       Impact factor: 5.923

10.  The Novel miR-9600 Suppresses Tumor Progression and Promotes Paclitaxel Sensitivity in Non-small-cell Lung Cancer Through Altering STAT3 Expression.

Authors:  Cheng-Cao Sun; Shu-Jun Li; Feng Zhang; Ya-Dong Zhang; Zhen-Yu Zuo; Yong-Yong Xi; Liang Wang; De-Jia Li
Journal:  Mol Ther Nucleic Acids       Date:  2016-11-15       Impact factor: 10.183

View more
  7 in total

Review 1.  Small but Powerful: The Human Vault RNAs as Multifaceted Modulators of Pro-Survival Characteristics and Tumorigenesis.

Authors:  Stefano Gallo; EunBin Kong; Iolanda Ferro; Norbert Polacek
Journal:  Cancers (Basel)       Date:  2022-06-03       Impact factor: 6.575

Review 2.  MicroRNAs Involved in Small-cell Lung Cancer as Possible Agents for Treatment and Identification of New Targets.

Authors:  Ulrich H Weidle; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2021 Sep-Oct       Impact factor: 4.069

3.  Aspirin ameliorates lung cancer by targeting the miR-98/WNT1 axis.

Authors:  Huizhu Gan; Lin Lin; Nanjun Hu; Yang Yang; Yu Gao; Yu Pei; Kang Chen; Butong Sun
Journal:  Thorac Cancer       Date:  2019-02-12       Impact factor: 3.500

4.  Amniotic Fluid microRNA in Severe Twin-Twin Transfusion Syndrome Cardiomyopathy-Identification of Differences and Predicting Demise.

Authors:  Eleanor L Schuchardt; Shelley D Miyamoto; Timothy Crombleholme; Anis Karimpour-Fard; Armin Korst; Bonnie Neltner; Lisa W Howley; Bettina Cuneo; Carmen C Sucharov
Journal:  J Cardiovasc Dev Dis       Date:  2022-01-23

5.  Methylation status of nc886 epiallele reflects periconceptional conditions and is associated with glucose metabolism through nc886 RNAs.

Authors:  Saara Marttila; Leena E Viiri; Pashupati P Mishra; Brigitte Kühnel; Pamela R Matias-Garcia; Leo-Pekka Lyytikäinen; Tiina Ceder; Nina Mononen; Wolfgang Rathmann; Juliane Winkelmann; Annette Peters; Mika Kähönen; Nina Hutri-Kähönen; Markus Juonala; Katriina Aalto-Setälä; Olli Raitakari; Terho Lehtimäki; Melanie Waldenberger; Emma Raitoharju
Journal:  Clin Epigenetics       Date:  2021-07-22       Impact factor: 6.551

6.  OSCC Exosomes Regulate miR-210-3p Targeting EFNA3 to Promote Oral Cancer Angiogenesis through the PI3K/AKT Pathway.

Authors:  Hui Wang; Lin Wang; Xiaocheng Zhou; Xinyue Luo; Ke Liu; Erhui Jiang; Yang Chen; Zhe Shao; Zhengjun Shang
Journal:  Biomed Res Int       Date:  2020-07-08       Impact factor: 3.411

Review 7.  Current Status of microRNA-Based Therapeutic Approaches in Neurodegenerative Disorders.

Authors:  Sujay Paul; Luis Alberto Bravo Vázquez; Samantha Pérez Uribe; Paula Roxana Reyes-Pérez; Ashutosh Sharma
Journal:  Cells       Date:  2020-07-15       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.